We just received data on a new analyst forecast for $CNTX. William Blair gave a rating of 'Outperform' for $CNTX.
$CNTX Analyst Ratings
Wall Street analysts have issued reports on $CNTX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/21/2025
To track analyst ratings and price targets for $CNTX, check out Quiver Quantitative's $CNTX forecast page.
$CNTX Hedge Fund Activity
We have seen 26 institutional investors add shares of $CNTX stock to their portfolio, and 16 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MPM BIOIMPACT LLC added 14,705,882 shares (+inf%) to their portfolio in Q4 2024, for an estimated $15,441,176
- GREAT POINT PARTNERS LLC removed 2,251,271 shares (-32.5%) from their portfolio in Q4 2024, for an estimated $2,363,834
- FRANKLIN RESOURCES INC added 2,149,392 shares (+115.9%) to their portfolio in Q4 2024, for an estimated $2,256,861
- VELAN CAPITAL INVESTMENT MANAGEMENT LP removed 1,200,323 shares (-93.0%) from their portfolio in Q4 2024, for an estimated $1,260,339
- BLUE OWL CAPITAL HOLDINGS LP added 946,638 shares (+17.5%) to their portfolio in Q4 2024, for an estimated $993,969
- UBS GROUP AG added 697,412 shares (+40618.1%) to their portfolio in Q4 2024, for an estimated $732,282
- VANGUARD GROUP INC removed 489,498 shares (-13.1%) from their portfolio in Q4 2024, for an estimated $513,972
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
